GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guerbet SA (XPAR:GBT) » Definitions » Ending Cash Position

Guerbet (XPAR:GBT) Ending Cash Position : €51.0 Mil (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Guerbet Ending Cash Position?

Guerbet's Ending Cash Position for the quarter that ended in Dec. 2023 was €51.0 Mil.

Guerbet's quarterly Ending Cash Position declined from Dec. 2022 (€41.4 Mil) to Jun. 2023 (€38.5 Mil) but then increased from Jun. 2023 (€38.5 Mil) to Dec. 2023 (€51.0 Mil).

Guerbet's annual Ending Cash Position declined from Dec. 2021 (€115.6 Mil) to Dec. 2022 (€41.4 Mil) but then increased from Dec. 2022 (€41.4 Mil) to Dec. 2023 (€51.0 Mil).


Guerbet Ending Cash Position Historical Data

The historical data trend for Guerbet's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guerbet Ending Cash Position Chart

Guerbet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.48 93.04 115.56 41.43 51.03

Guerbet Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.56 59.92 41.43 38.46 51.03

Guerbet Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Guerbet's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=41.433+9.599
=51.0

Guerbet's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=38.459+12.573
=51.0


Guerbet Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Guerbet's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Guerbet (XPAR:GBT) Business Description

Traded in Other Exchanges
Address
15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.

Guerbet (XPAR:GBT) Headlines

From GuruFocus

GBT Announces New Employment Inducement Grants

By PurpleRose PurpleRose 07-12-2022